Institutional Ownership Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP). We have compiled data on the 63 institutions that hold shares in the stock, with a total of 42 Million shares, which have been reported (via 13F filing form) to have a value of $1.26 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Columbia Advisory Partners LLC
|
Oct 24, 2025 Q3 2025 |
36,730
shares
|
$1,101
0.0% of portfolio
|
Q2 2025
Added 0.55%
|
|
|
Simon Quick Advisors, LLC
|
Oct 21, 2025 Q3 2025 |
30,000
shares
|
$900
0.0% of portfolio
|
Q4 2024
Reduced 1.48%
|
|
|
Sg Americas Securities, LLC
|
Oct 23, 2025 Q3 2025 |
27,497
shares
|
$824
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Legacy Capital Wealth Management, LLC
The Woodlands, TX |
Jun 04, 2025 Q4 2024 |
27,080
shares
|
$812
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Nov 14, 2025 Q3 2025 |
25,261
shares
|
$757
0.0% of portfolio
|
Q1 2025
Reduced 18.73%
|
|
|
Prosperity Wealth Management, Inc.
San Ramon, CA |
Nov 14, 2025 Q3 2025 |
19,227
shares
|
$576
0.0% of portfolio
|
Q3 2025
Reduced 2.71%
|
|
|
Stone X Group Inc.
|
Nov 14, 2025 Q3 2025 |
15,040
shares
|
$451
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Traynor Capital Management, Inc.
|
Nov 03, 2025 Q3 2025 |
15,000
shares
|
$450
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Simplex Trading, LLC
|
Nov 12, 2025 Q3 2025 |
12,424
shares
|
$372
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
12,320
shares
|
$369
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Rockefeller Capital Management L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
12,166
shares
|
$364
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Ifg Advisory, LLC
|
Nov 12, 2025 Q3 2025 |
11,725
shares
|
$351
0.0% of portfolio
|
Q2 2025
Added 17.25%
|
|
|
X Square Capital, LLC
|
Nov 10, 2025 Q3 2025 |
11,573
shares
|
$347
0.0% of portfolio
|
Q3 2025
Added 3.58%
|
|
|
Kornitzer Capital Management Inc
|
Oct 31, 2025 Q3 2025 |
10,000
shares
|
$300
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 06, 2025 Q3 2025 |
5,743
shares
|
$172
0.0% of portfolio
|
Q3 2025
Reduced 32.7%
|
|
|
Lindbrook Capital, LLC
|
May 05, 2025 Q1 2025 |
4,610
shares
|
$138
0.0% of portfolio
|
Q4 2024
Reduced 4.89%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
2,700
shares
|
$81
0.0% of portfolio
|
Q3 2025
Reduced 94.48%
|
|
|
Citigroup Inc
|
Nov 10, 2025 Q3 2025 |
2,679
shares
|
$80
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
2,534
shares
|
$76
0.0% of portfolio
|
Q2 2025
Reduced 94.94%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Nov 14, 2025 Q3 2025 |
2,058
shares
|
$61
0.0% of portfolio
|
Q3 2025
Reduced 97.71%
|
|
|
Sandy Spring Bank
|
May 12, 2025 Q1 2025 |
1,050
shares
|
$31
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2025 Q3 2025 |
700
shares
|
$21
0.0% of portfolio
|
Q3 2025
Reduced 93.59%
|
|
|
Bryn Mawr Trust CO
Bryn Mawr, PA |
Nov 20, 2025 Q3 2025 |
604
shares
|
$18
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Carmichael Hill & Associates, Inc.
|
Oct 29, 2024 Q3 2024 |
525
shares
|
$15
0.0% of portfolio
|
Q1 2022
Added 50.0%
|
|
|
High Mark Wealth Management LLC
|
Oct 20, 2025 Q3 2025 |
287
shares
|
$8
0.0% of portfolio
|
Q3 2023
Reduced 77.38%
|
|